Last reviewed · How we verify

Iron-folic acid supplement

Johns Hopkins Bloomberg School of Public Health · Phase 1 active Small molecule

Iron-folic acid supplement is a Small molecule drug developed by Johns Hopkins Bloomberg School of Public Health. It is currently in Phase 1 development.

At a glance

Generic nameIron-folic acid supplement
SponsorJohns Hopkins Bloomberg School of Public Health
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Iron-folic acid supplement

What is Iron-folic acid supplement?

Iron-folic acid supplement is a Small molecule drug developed by Johns Hopkins Bloomberg School of Public Health.

Who makes Iron-folic acid supplement?

Iron-folic acid supplement is developed by Johns Hopkins Bloomberg School of Public Health (see full Johns Hopkins Bloomberg School of Public Health pipeline at /company/johns-hopkins-bloomberg-school-of-public-health).

What development phase is Iron-folic acid supplement in?

Iron-folic acid supplement is in Phase 1.

Related